A., ... & Schalken, J. A. (2016). Detection of high-grade prostate cancer using a urinary molecular
prior to radical prostatectomy (RP) in men with high-risk localized prostate cancer (PC).
LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC) 高危局限性前列腺癌应用阿帕
参考文献 [1]Hoyle AP, et al. Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate
Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.癌症和白血病 B 组 90203(联盟): 局部高危